NewAmsterdam Pharma Company
NAMS
#4424
Rank
A$2.88 B
Marketcap
$31.22
Share price
1.85%
Change (1 day)
115.68%
Change (1 year)

NewAmsterdam Pharma Company (NAMS) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : A$92.4 Million

According to NewAmsterdam Pharma Company's latest financial reports the company's total liabilities are A$92.4 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

NewAmsterdam Pharma Company - Total liabilities on balance sheet (from 2023 to 2023)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$86.16 M12.87%
2022-12-31A$76.34 M332.02%
2021-12-31A$17.67 M-29.88%
2020-12-31A$25.19 M